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Case
A 51-year-old male patient was admitted to the
emergency room with the complaint of vomiting blood.
There was no history of peptic ulcer and anticoagulant
therapy or therapy with drugs irritating to the mucosa.
He defined an abdominal pain that had spread to the back
during the previous week. On physical examination he
was pale, blood pressure was 90/50 mmHg, pulse rate
was 100/min, and respiratory rate was 25/min. He was
conscious and orientation was impaired slightly.
Hematemesis and melena were determined by
nasogastric intubation and rectal examination.
Laboratory findings were as follows: Hemoglobin
concentration = 7.8g/dl, RBC = 2.2 million/ml, WBC =
6.750/ml, thrombocyte concentration = 222.000/ml.,
serum glucose = 110 mg/dl., BUN = 63 mg/ml.
In endoscopic examination, a large bleeding bulbar
ulceration suspected of malignancy was detected and
sclerotherapy was performed but it was not possible to
perform a biopsy because of massive bleeding. Proper
medical treatment was started immediately but 8 hours
after endoscopic sclerotherapy, the bleeding occurred
again. Surgical intervention was decided on, and the
patient underwent urgent surgery after a short
preparation. A mid-line incision was made. During the
mobilization of the duodenum a mass 5 cm in diameter
was noticed on the head of pancreas. In addition, multiple
lymph nodes were present around the duodenum. It was
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difficult to determine whether this mass lesion was due to
an ulcer penetration or a primary tumor. There was no
evidence of malignancy in the excised lymph nodes on
frozen section examination. It was decided to perform the
Whipple procedure because of the high malignancy risk of
pancreatic masses, in spite of the inappropriate
hemodynamic condition.
The patient was removed from mechanical ventilation
support on the 3rd postoperative day, transported from
the intensive care unit to the ward on the 18th
postoperative day and discharged from the hospital on
the 26th postoperative day. The histopathological
diagnosis was reported to be pancreatic endocrine
neoplasm, chronic pancreatitis, and reactive lymph nodes.
Figure 1 shows the pancreatic endocrine neoplasm in
the structure of chronic pancreatitis.
Gastrin production by the neoplastic cells was shown
by immunohistochemistry. The immunoperoxidase
technique was performed on the paraffin embedded
tumor tissue. Tumor cells exhibited positive
immunoreactivity with gastrin (Figures 2, 3).
Upper gastrointestinal system bleeding occurs due to
various causes and may be recognized by symptoms such
as hematemesis, melena and shock (1-3). Generally,
frequent causes of upper gastrointestinal system bleeding
may be considered during primary evaluation. However,
definite diagnosis requires endoscopic examination (4). In
differential diagnosis, Mallory-Weiss syndrome, Deulafoy
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syndrome, vascular malformations, hemobilia, aortoenteric fistulas, penetration of pancreas pseudocysts, and
invasion of secondary tumors should be considered (2, 3).
Pancreas tumors can be divided into the two basic
groups of endocrine and exocrine tumors. Endocrine
tumors are rarely seen (one per million), and the majority
of them are functional tumors originating from alpha,
beta and delta type islet cells (5, 6). Many of them are
benign and recognized by clinical features that are specific
to their origin. Also, some of them are diagnosed
accidentally during investigations for completely different
reasons (6).
Figure 1.

Pancreatic endocrine neoplasm in the center of the
structure of chronic pancreatitis. (HE x100).

Figure 2.

Microscopic view. Gastrinoma stained for gastrin and a
group of neoplastic cells show strong positivity. (Gastrin,
immunperoxidase x400).

It is not usual that a pancreas tumor causes upper
gastrointestinal system bleeding or appears with an
ulceration other than gastrinoma. In our patient, the
cause of bleeding was thought to be the invasion and
ulceration of a pancreas tumor or the cause of the mass
was thought to be penetration of the gastric ulcer.
However, histopathological examination showed a lesion
3 mm in diameter of pancreas endocrine neoplasm in the
structure
of
chronic
pancreatitis.
Later,
immunohistochemical analysis proved that the lesion was
a gastrinoma. There was no sign or history of
gastrinoma, and tumor was perceptible primarily by
bleeding. For this reason, the serum gastrin level was not
measured.
An important presenting sign that should suggest ZES
is prominent gastric body folds, which were noted on
endoscopy in 94% of patients; however, a correct
diagnosis of ZES was made by the referring physician
initially in only 3% of the patients (7).
The Whipple procedure is superior to other
procedures performed for pancreatic malignant lesions,
and may be preferable for disease located primarily in the
head of the gland (6, 8). A marked reduction in the
morbidity and mortality rates after the Whipple
procedure has been reported and it has been used to
resect pancreatic endocrine neoplasms successfully (9).
Surgery represents the only way to cure these lesions
(10).

Figure 3.
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High power view of gastrin staining of pancreatic
gastrinoma. There is scattered positivity. A neoplastic cell
showing strong gastrin positivity is seen in the upper right
corner. (Gastrin, immunperoxidase x400).

This patient was evaluated as having upper
gastrointestinal system bleeding and we decided to
operate for this reason. In the course of the operation we
could not be sure of the origin of the mass, although the
frozen section examination result was negative for
malignancy. We accepted the risk of the Whipple
procedure in such inappropriate metabolic and
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hemodynamic condition. Determination of endocrine
neoplasm at postoperative histopathologic examination
verified that the early intervention was accurate because
there was no local lymphatic invasion or distant organ
metastases.
In conclusion, when patients with upper
gastrointestinal system bleeding are evaluated the
possibility of a pancreatic tumor must be considered, and

if such a condition is observed peroperatively, we believe
more extensive surgical procedure, must be considered.
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